PPH CoP Monica Arribas Presentation

The presentation discusses the pharmacokinetics and safety of tranexamic acid (TXA) in women giving birth by cesarean section. The presentation highlights the importance of early administration of TXA in reducing the risk of death from bleeding and the need for alternative routes of TXA administration, including oral and intramuscular routes. The presentation also outlines the design and outcomes of a trial, Woman-PharmacoTXA, which aims to assess the pharmacokinetics, safety, and efficacy of different routes of TXA administration in women giving birth by cesarean section.